Human-anti-human CD3 binding molecules
Details for Australian Patent Application No. 2004242845 (hide)
International Classifications
Event Publications
3 November 2005 PCT application entered the National Phase
PCT publication WO2004/106380 Priority application(s): WO2004/106380
2 June 2011 Application Accepted
Published as AU-B-2004242845
29 September 2011 Standard Patent Sealed
20 September 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Amgen Research (Munich) GmbH . Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 20 324 Queen Street Brisbane QLD 4000
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser